Technology

Tracking early warning signs of relapse: what works

April 10, 2026 9 min read

One of the most striking findings in schizophrenia research is how rarely relapse arrives suddenly. In retrospect, almost everyone — patients, families, clinicians — can identify a window of one to four weeks before the acute episode where things were already changing. Sleep started to shift. The person became more withdrawn. They missed a few doses. Energy fell or rose strangely. Mood frayed. The pattern is so consistent that the field has spent decades developing tools to catch it earlier, on the theory that early intervention can prevent or shorten an episode.

The challenge is that the patterns are personal. The early warning signs that matter for one person may be irrelevant for another. Generic checklists help, but the most useful tracking is calibrated to the individual.

In one sentence

The best early warning systems combine a short personalised list of an individual's specific prodromal signs, a simple way to record them daily, and a person who will be told if the pattern emerges.

Why early warning tracking helps

The Cochrane review of early intervention for psychosis (Marshall and Rathbone, last updated in 2011) showed that programs combining early detection with rapid response reduce relapse, hospitalisation, and disability. More recent work from the Yale and Melbourne early-psychosis groups continues to support this. The mechanism is not subtle: a clinician who hears about a sleep collapse on day three of a slide can adjust medication, intensify support, or schedule a quick review. A clinician who hears about it three weeks later, after a hospital admission, has many fewer options.

What to track

Generic warning signs — drawn from large studies and the experience of many clinicians — fall into a few categories:

The more useful version of this list is the personal one. Most people, looking back at one or two past episodes, can identify three to five signs that consistently appeared first for them. Those personalised signs are what to track. See early warning signs of schizophrenia for a longer discussion.

How to track without the tracking becoming the problem

The classic risk in mental health tracking is that the act of monitoring symptoms becomes its own source of anxiety. Five-minute morning rituals are sustainable. Twenty-minute symptom inventories are not.

Practical guidelines:

Tools that exist

Paper

The original early warning tool is a piece of paper on the fridge with the patient's specific signs and a simple grid. For some patients it remains the best tool — no apps, no batteries, no privacy questions, no friction. NAMI publishes templates for free.

Generic mood tracker apps

Daylio, Bearable, eMoods, and similar apps allow flexible custom tracking with low friction. They were not designed for schizophrenia specifically and lack disorder-specific prompts, but they are cheap, private, and customisable.

Schizophrenia-specific tools

A small number of apps have been built specifically for psychosis self-management — for example, the FOCUS app developed by Dror Ben-Zeev's group at the University of Washington (described in the Schizophrenia Bulletin, 2014, and subsequent papers), which combines symptom tracking with brief on-demand interventions. Most are research-stage and not commercially available.

Passive sensing

Smartphone passive sensing — tracking call patterns, screen time, location radius, sleep estimates from the phone — is an active research area. The most cited work, including Torous and colleagues' MindLAMP platform, has shown that passive features can detect changes that precede relapse. Consumer-grade passive sensing for schizophrenia, validated and packaged for routine use, is still emerging.

Wearable-derived data

Sleep duration and resting heart rate from a basic Fitbit or smartwatch produce a stable trend line that reveals shifts well. See wearables for schizophrenia.

The Frida approach

Frida combines a short personalised early-warning checklist, simple daily mood and sleep ratings, and an option to share trends with a designated family member or care coordinator. We describe the design in how Frida tracks cognitive stability. Like any tool, it works best when paired with a real person in the loop.

The relapse prevention plan

Tracking is only useful if it triggers action. The most evidence-supported framework, drawn from the work of the late Max Birchwood and colleagues, is a written plan with three zones:

The plan should be written in advance, when the patient is well, and shared with at least one trusted person. The whole point is that decisions are made when judgement is clear, not in the middle of a slide.

If you reach the red zone

Contact your prescriber, your local crisis service, or a trusted person. In the US, call or text 988. See when to call 911 for mental health.

What to ask your prescriber

  1. What were my earliest signs in past episodes?
  2. What three to five things should I track day to day?
  3. What is our agreed plan if those things start to slip?
  4. Who can I call between visits if I need to?
  5. Is there someone in my life who should be told, with my consent, if I move into a yellow zone?

The honest summary

No tool prevents every relapse. Some episodes still arrive faster than tracking can catch them, and some patients lose insight into their own warning signs as an episode emerges — which is exactly why pre-agreed plans and trusted people matter. But across the literature, the combination of personalised tracking, written relapse prevention plans, and rapid clinical response reduces hospitalisations and shortens episodes when they do happen. That is a meaningful effect, achieved with simple tools.


This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.

Frequently asked questions

How early do warning signs of relapse usually appear?
Most patients in research studies show identifiable early signs one to four weeks before a full relapse. The window varies; some episodes arrive faster, some give months of warning. The averages support the value of weekly check-ins.
What if I lose insight into my warning signs as I get unwell?
This is common and expected. It is one of the strongest arguments for sharing your tracking, with consent, with a trusted person — a parent, partner, sibling, or care coordinator who can see patterns you may not.
Do I have to use an app?
No. A piece of paper on the fridge with three to five personal signs is a perfectly good tracking system for many patients. The best tool is the one you'll actually use.
Will tracking make me more anxious about my symptoms?
It can, especially at first. The protective design is to track simply, briefly, and at a fixed time, and to look at trends over weeks rather than reacting to single days. If tracking is feeding anxiety, talk to your clinician about adjusting the approach.

Try Frida — your calm companion

Frida helps people living with schizophrenia track moods, manage medication, and build stability. 7-day free trial.

Get the app →